Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2019-05-01
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases
NCT02214303
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
NCT03644680
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835
Local IgE in Subjects With Allergic or Non-allergic Rhinitis
NCT02810535
Airway Inflammation in Children With Allergic Rhinitis and Intervention
NCT02352168
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Allergic rhinitis patients
Nasal provocation test
Allergen extract under controlled conditions will be applied into nasal mucous.
Allergic rhinitis and asthma patients
Nasal provocation test
Allergen extract under controlled conditions will be applied into nasal mucous.
Healthy individuals
Nasal provocation test
Allergen extract under controlled conditions will be applied into nasal mucous.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nasal provocation test
Allergen extract under controlled conditions will be applied into nasal mucous.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Allergic rhinitis with or without mild to moderate asthma
Exclusion Criteria
* Use of systemic immunosupresants (wait 1 month)
* Use of systemic or local antihistamines (wait 1 week)
* Use of intranasal steroids (wait 1 month)
* Oncological or active autoimmune diseases
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lithuanian University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brigita Sitkauskiene
Prof., Head of Department of Immunology and Allergology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AKTL1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.